Cymabay Therapeutics Inc

NASDAQ:CBAY   3:59:52 PM EDT
3.89
+0.09 (+2.37%)
Earnings Announcements

Cymabay Reports Second Quarter And Six Months Ended June 30, 2021 Financial Results And Provides Corporate Update

Published: 08/12/2021 22:17 GMT
Cymabay Therapeutics Inc (CBAY) - Cymabay Reports Second Quarter and Six Months Ended June 30, 2021 Financial Results and Provides Corporate Update.
Cymabay Therapeutics - Qtrly Loss per Share $0.34.
Revenue is expected to be $6.25 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $8.75 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.